Beclomethasone Dipropionate & Clotrimazole is used for Relief of itching, Burning, Cracking, And scaling associated with athlete's foot, Jock itch and ringworm, Treatment of ringworm, Allergic rhinitis, Treatment of jock itch, Treatment of athlete's foot, Prevention of oral thrush, Fungal infections of armpit and skin folds and other conditions. This salt combination may also be used for purposes not listed in this medication guide. Detailed information related to Beclomethasone Dipropionate & Clotrimazole's uses, side-effects, reviews, questions, interactions, and precautions
“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More”
Ok, I agree
Merck Sharp & Dohme Corp.Trade Name : Lotrisone
CREAM
Strength 10.5 mg/gmg/g
Storage and handling for Lotrisone
CLOTRIMAZOLE; BETAMETHASONE DIPROPIONATE Azole Antifungal [EPC],Azoles [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
Disclaimer
GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Clotrimazole And Betamethasone Dipropionate (Lotrisone) which is also known as Lotrisone and Manufactured by Merck Sharp & Dohme Corp.. It is available in strength of 10; .5 mg/g; mg/g per
ml. Read more
Clotrimazole And Betamethasone Dipropionate (Lotrisone) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price. Read less
Delivery Process
Submit a Request
You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.
We’ll Get in Touch
Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.
Confirmation and Payment
You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.
Submit a Request
You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.
Product information is meant for
Packaging and Delivery
Validated Cold Chain Shipment
We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.
We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.
Read more
About GNH
We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.
We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.
Read more
- No data
- LOTRISONE cream is a combination of an azole antifungal and corticosteroid and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to , , and in patients 17 years and older.
- LOTRISONE cream contains a combination of clotrimazole, an azole antifungal, and betamethasone dipropionate, a corticosteroid, and is indicated for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to , , and in patients 17 years and older. ()
- Treatment of tinea corporis or tinea cruris:
- Treatment of tinea pedis:
- LOTRISONE cream is for topical use only. It is not for oral, ophthalmic, or intravaginal use.
- Avoid contact with eyes. Wash hands after each applicationn
- Tinea pedis:
- Tinea cruris and tinea corporis:
- Do not use with occlusive dressings unless directed by a physician. ()
- Not for ophthalmic, oral or intravaginal use. ()
- Cream, 1%/0.05%. Each gram of LOTRISONE cream contains 10 mg of clotrimazole and 0.643 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone) in a white to off-white cream base.
- Cream, 1%/0.05% ()
- Each gram of LOTRISONE cream contains 10 mg of clotrimazole and 0.643 mg of betamethasone dipropionate (equivalent to 0.5 mg of betamethasone) ()
- None.
- None. ()
- No data
- LOTRISONE cream can cause reversible HPA axis suppression with the potential for glucocorticosteroid insufficiency during and after withdrawal of the treatment. Risk factor(s) are: use of high-potency topical corticosteroid, use over a large surface area or to areas under occlusion, prolonged use, altered skin barrier, liver failure, and young age. Modify use should HPA axis suppression develop. (, )
- Pediatric patients may be more susceptible to systemic toxicity. (, )
- The use of LOTRISONE cream in the treatment of diaper dermatitis is not recommended. ()
- Topical corticosteroid products may increase the risk of cataracts and glaucoma. If visual symptoms occur, consider referral to an ophthalmologist. ()
- Most common adverse reactions reported for LOTRISONE cream were paraesthesia in 1.9% of patients and rash, edema, and secondary infections each in less than 1% of patients. ()
- To report SUSPECTED ADVERSE REACTIONS, contact Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., at 1-877-888-4231 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
- No data
- LOTRISONE (clotrimazole and betamethasone dipropionate) cream, 1%/0.05%, contains combinations of clotrimazole, an azole antifungal, and betamethasone dipropionate, a corticosteroid, for topical use.
- Chemically, clotrimazole is 1u2013(o-chloro-u03b1,u03b1-diphenylbenzyl) imidazole, with the empirical formula CHCLN, a molecular weight of 344.84, and the following structural formula:
- Clotrimazole is an odorless, white crystalline powder, insoluble in water and soluble in ethanol.
- Betamethasone dipropionate has 9-fluoro-11u03b2,17,21-trihydroxy-16u03b2-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate, with the empirical formula CHFO, a molecular weight of 504.59, and the following structural formula:
- Betamethasone dipropionate is a white to creamy-white, odorless crystalline powder, insoluble in water.
- Each gram of LOTRISONE cream contains 10 mg clotrimazole and 0.643 mg betamethasone dipropionate (equivalent to 0.5 mg betamethasone), in a white to off-white, hydrophilic cream consisting of benzyl alcohol as a preservative, ceteareth-30, cetyl alcohol plus stearyl alcohol, mineral oil, phosphoric acid, propylene glycol, purified water, sodium phosphate monobasic monohydrate, and white petrolatum.
- No data
- Long-term animal studies have not been performed to evaluate the carcinogenic potential of the combination of clotrimazole and betamethasone dipropionate or either component individually.
- Betamethasone was negative in the bacterial mutagenicity assay ( and ) and in the mammalian cell mutagenicity assay (CHO/HGPRT). It was positive in the in vitro human lymphocyte chromosome aberration assay, and equivocal in the in vivo mouse bone marrow micronucleus assay.
- In a combined study of the effects of clotrimazole on fertility, embryofetal development, and postnatal development, male and female rats were dosed orally (diet admixture) with dose levels of 5, 10, 25, or 50 mg/kg/day from 10 weeks prior to mating until 4 weeks postpartum. No adverse effects on the duration of estrous cycle, fertility, or duration of pregnancy were noted.
- Reproductive studies with betamethasone dipropionate conducted in rabbits at doses of 1.0 mg/kg/day by the intramuscular route and in mice up to 33 mg/kg/day by the intramuscular route indicated no impairment of fertility except for dose-related increases in fetal resorption rates in both species.
- In clinical trials of tinea corporis, tinea cruris, and tinea pedis, subjects treated with LOTRISONE cream showed a better clinical response at the first return visit than subjects treated with clotrimazole cream. In tinea corporis and tinea cruris, the subject returned 3 to 5 days after starting treatment, and in tinea pedis, after 1 week. Mycological cure rates observed in subjects treated with LOTRISONE cream were as good as, or better than, in those subjects treated with clotrimazole cream. In these same clinical studies, patients treated with LOTRISONE cream showed better clinical responses and mycological cure rates when compared with subjects treated with betamethasone dipropionate cream.
- LOTRISONE cream is white to off-white and supplied in 15-gram (NDC 0085-0924-01) and 45-gram tubes (NDC 0085-0924-02), boxes of one. Store at 20-25u00b0C (68-77u00b0F); excursions permitted to 15-30u00b0C (59-86u00b0F) [see USP Controlled Room Temperature].
- Rx only
- Advise the patient to read the FDA-approved patient labeling (Patient Information).
- Inform the patient of the following:
- Distributed by: Merck Sharp & Dohme Corp., a subsidiary of n Whitehouse Station, NJ 08889, USA
- For patent information: www.merck.com/product/patent/home.html
- Copyright u00a9 1983-2019 Merck Sharp & Dohme Corp., a subsidiary of . All rights reserved.
- uspi-mk5335A-cr-1906r005
- usppi-mk5335A-cr-1906r005
- NDC 0085-0924-01
- 15 g
- Lotrisone
- cream,1%/0.05%
- FOR TOPICAL USE ONLY,NOT FOR OPHTHALMIC,ORAL, OR INTRAVAGINALUSE, NOT RECOMMENDEDFOR PATIENTS UNDERTHE AGE OF 17 YEARS ANDNOT RECOMMENDED FORDIAPER DERMATITIS.
- Rx only
Similar Products
Browse Our Services And Processes
Comparator Sourcing for Clinical Trials
GNH India brings over 10 years of experience in Comparator
Read More
Name Patient Supply
Today, the exact cause for many rare diseases remains unknown
Read More
Validated Cold Chain Shipment
With shifting of pharma industry from synthetic molecules to biologic
Read More
Clinical Trials Supply
STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE
Read More
Dossiers and Stability Studies
STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active
Read More
Pharmaceutical Contract Manufacturing
GNH Provides Contract Manufacturing services for: Generic Medicines with following
Read More
Pricing
PRICING POLICY Terms of sales are typically prepaid, unless otherwise
Read More
Disclaimer
Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.
Browse from other international pharmaceuticals
General
64036 Products
GNH India brings over 10 years of experience in Comparator Sourcing services from India and RoW markets.
US NDC
71259 Products
GNH India brings over 10 years of experience in Comparator Sourcing services from India and RoW markets.
Canadian DIN
51047 Products
GNH India brings over 10 years of experience in Comparator Sourcing services from India and RoW markets.
Swiss Drugs
150 Products
GNH India brings over 10 years of experience in Comparator Sourcing services from India and RoW markets.
NZ Drugs
13298 Products
GNH India brings over 10 years of experience in Comparator Sourcing services from India and RoW markets.
FAQ
Check out our delivery process